palmitoylethanolamide.com.au
HomeResearchMartina 2024

Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials

Martina D'Angelo, Luca Steardo Jr. Int J Mol Sci. 2024 Mar 22;25(7):3603.

ReviewHumans

Design
Review
Subjects
Not stated in the abstract
Dose used in the study
Not stated in the abstract
Duration
Not stated in the abstract
What was measured
How THC, CBD and palmitoylethanolamide affect sleep regulation and sleep disorders

What the authors reported

This review reported:

  • THC can promote sleep at first but alters sleep architecture with long-term use, the authors write.
  • CBD is reported to improve sleep quality without psychoactive effects.
  • PEA is described as acting on the endocannabinoid system and PPAR receptors, with a favourable safety profile cited for CBD and PEA.
  • They call for research on dosage, safety and efficacy in different patient groups.

Limits of this study

A narrative review with no new data, search method or trial list in the abstract. It gives no numbers on how PEA affected sleep. The authors declare no conflicts of interest.

Source

PubMed 38612415 · doi:10.3390/ijms25073603

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.